PTSDgene database

Study Report

Study Information
Basic Info
Reference
Citation Kimbrel, N. A., et al. (2015). "EFFECT OF THE APOE epsilon4 ALLELE AND COMBAT EXPOSURE ON PTSD AMONG IRAQ/AFGHANISTAN-ERA VETERANS." Depress Anxiety 32(5): 307-315.
Phenotype Lifetime PTSD, PTSD symptom severity
Trauma Iraq/Afghanistan-era war
Study Design Case-control
Study Type Candidate gene association study, Gene-environment interaction study
Sample Size 765 NHW and 859 NHB Iraq/Afghanistan-era veterans (total N=1,624)
SNP/Marker Size 1 Variant
Predominant Ethnicity Black, Caucasian
Population 765 non-Hispanic White (NHW) and 859 non-Hispanic Black (NHB)
Gender 79.5% male
Age No detial information.

Detail Info

Genetic result reported by this study
Gene * Environment result reported by this study (count: 2)
Marker Phenotype Related Gene Environment Statistical Values Author Comments Marker's Category
APOE_euro4 PTSD symptom severity APOE Combat exposure (The Combat Exposure Scale, CES) APOE and combat exposure interaction to predict current PTSD symptom severity: P-value= .0009, with high combat exposure: P-value= .0011. No significant G x E effects were observed within the NHW sa...... No significant G x E effects were observed within the NHW sample. APOE and combat exposure also interacted to predict current PTSD symptom severity. Again, as the number of euro4 alleles increased, the mean severity score on the DTS increased by 10.25 points, but only among those with high combat exposure. More... Significant
APOE_euro4 Lifetime PTSD APOE Combat exposure (The Combat Exposure Scale, CES) Interaction between APOE and combat exposure for lifetime PTSD diagnosis: P-value= .0029, with high combat exposure: P-value=.0077. No significant G x E effects were observed within the NHW sa...... No significant G x E effects were observed within the NHW sample. In contrast, significant G x E effects were observed for all three of the main outcomes examined in the NHB sample (all P's < .0083). A significant interaction between APOE and combat exposure was observed for lifetime PTSD diagnosis. For each additional euro4 allele, the odds of having a lifetime PTSD diagnosis increased by 1.61, but only among those with high combat exposure. The rates of lifetime PTSD among the high combat exposure group were 49.3% for participants with no euro4 alleles, 56.4% for those with one euro4 allele, and 92.3% for those with two euro4 alleles (Fig. 1). More... Significant